Personal Information

Yunlong Hou, Harbin Medical University, Associate Professor.

Research Fields

Cardiovascular Pharmacology, Drug research & Development

Work Experience

10.2011- Present  Associate Professor, Harbin Medical University

10.2011               Instructor, Harbin Medical University

07.2011               Harbin Medical University, Ph.D. in Pharmacology

07.2008               Harbin Medical University, M.S. in Pharmacology

05.2007               Visiting Scholar, Sanwa Kagaku Kenkyusho Co., Ltd., Japan

03.2005               Assistant researcher, Harbin Medical University

07.2001               Harbin Medical University,B.S. in Clinical Medicine

Paper Submission

1. Kato, N., Y. Hou, et al. (2009). Kallidinogenase normalizes retinal vasopermeability in streptozotocin-induced diabetic rats: potential roles ofvascular endothelial growth factor and nitric oxide. Eur J Pharmacol 606(1-3), 187-190
2. Hou, Y., S. Fan, et al. (2010). Pharmacokinetic study of mangiferin in rat plasma and retina using high-performance liquid chromatography. Mol Vis 16: 1659-1668
3. Tang, J. S., Y. L. Hou, et al. (2011). Polyphenols from Parabarium huaitingii and their positive inotropic and anti-myocardial infarction effectsin rats. Phytomedicine 18(7): 544-550
4. Zhu, J., R. Xie, et al. (2012). Homocysteine enhances clot-promoting activity of endothelial cells via phosphatidylserine externalization andmicroparticles formation. Amino Acids 43(3): 1243-1250
5. Yang, Y., X. Piao, et al. (2012). Bioactivity-guided fractionation of the triglyceride-lowering component and in vivo and in vitro evaluation ofhypolipidemic effects of Calyx seu Fructus Physalis. Lipids Health Dis 11:38
6. Hou, Y., Y. Sun, et al. (2012). Beta-adrenoceptor regulates miRNA expression in rat heart. Med Sci Monit 18(8): BR309-314